These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 20818158

  • 21. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
    Lin L, Benson DM, DeAngelis S, Bakan CE, Li PK, Li C, Lin J.
    Int J Cancer; 2012 Mar 15; 130(6):1459-69. PubMed ID: 21520044
    [Abstract] [Full Text] [Related]

  • 22. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.
    Li W, Zhang Q, Chen K, Sima Z, Liu J, Yu Q, Liu J.
    BMC Complement Altern Med; 2019 Feb 01; 19(1):38. PubMed ID: 30709346
    [Abstract] [Full Text] [Related]

  • 23. Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition.
    Chiablaem K, Lirdprapamongkol K, Keeratichamroen S, Surarit R, Svasti J.
    Anticancer Res; 2014 Apr 01; 34(4):1857-64. PubMed ID: 24692720
    [Abstract] [Full Text] [Related]

  • 24. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.
    Bharti AC, Donato N, Aggarwal BB.
    J Immunol; 2003 Oct 01; 171(7):3863-71. PubMed ID: 14500688
    [Abstract] [Full Text] [Related]

  • 25. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
    Chakravarti N, Myers JN, Aggarwal BB.
    Int J Cancer; 2006 Sep 15; 119(6):1268-75. PubMed ID: 16642480
    [Abstract] [Full Text] [Related]

  • 26. Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition.
    Gao L, Wang L, Sun Z, Li H, Wang Q, Yi C, Wang X.
    Drug Des Devel Ther; 2017 Sep 15; 11():1789-1802. PubMed ID: 28670112
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.
    Sethi G, Chatterjee S, Rajendran P, Li F, Shanmugam MK, Wong KF, Kumar AP, Senapati P, Behera AK, Hui KM, Basha J, Natesh N, Luk JM, Kundu TK.
    Mol Cancer; 2014 Mar 21; 13():66. PubMed ID: 24655440
    [Abstract] [Full Text] [Related]

  • 28. STAT3 activation in monocytes accelerates liver cancer progression.
    Wu WY, Li J, Wu ZS, Zhang CL, Meng XL.
    BMC Cancer; 2011 Dec 05; 11():506. PubMed ID: 22136659
    [Abstract] [Full Text] [Related]

  • 29. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.
    Rajendran P, Ong TH, Chen L, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Hui KM, Sethi G.
    Clin Cancer Res; 2011 Mar 15; 17(6):1425-39. PubMed ID: 21131551
    [Abstract] [Full Text] [Related]

  • 30. IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling.
    Pu XY, Zheng DF, Shen A, Gu HT, Wei XF, Mou T, Zhang JB, Liu R.
    Hepatobiliary Pancreat Dis Int; 2018 Oct 15; 17(5):408-415. PubMed ID: 30201411
    [Abstract] [Full Text] [Related]

  • 31. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B.
    Oncol Rep; 2017 Aug 15; 38(2):1224-1232. PubMed ID: 28677802
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
    Miyakoshi M, Yamamoto M, Tanaka H, Ogawa K.
    Mol Carcinog; 2014 Jan 15; 53(1):67-76. PubMed ID: 22911886
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of antitumor activity of Artemisia capillaris extract against hepatocellular carcinoma through the inhibition of IL-6/STAT3 signaling axis.
    Jang E, Kim SY, Lee NR, Yi CM, Hong DR, Lee WS, Kim JH, Lee KT, Kim BJ, Lee JH, Inn KS.
    Oncol Rep; 2017 Jan 15; 37(1):526-532. PubMed ID: 28004112
    [Abstract] [Full Text] [Related]

  • 35. Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway.
    Zhang J, Li Z, Liu L, Wang Q, Li S, Chen D, Hu Z, Yu T, Ding J, Li J, Yao M, Huang S, Zhao Y, He X.
    Hepatology; 2018 Jan 15; 67(1):171-187. PubMed ID: 28746790
    [Abstract] [Full Text] [Related]

  • 36. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 37. A new xanthatin analogue 1β-hydroxyl-5α-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma.
    Fang XY, Zhang H, Zhao L, Tan S, Ren QC, Wang L, Shen XF.
    Biochimie; 2018 Sep 15; 152():43-52. PubMed ID: 29960031
    [Abstract] [Full Text] [Related]

  • 38. Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.
    Ploeger C, Waldburger N, Fraas A, Goeppert B, Pusch S, Breuhahn K, Wang XW, Schirmacher P, Roessler S.
    Hepatology; 2016 Sep 15; 64(3):828-42. PubMed ID: 27311882
    [Abstract] [Full Text] [Related]

  • 39. TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma.
    Wang C, Dou C, Wang Y, Liu Z, Roberts L, Zheng X.
    Int J Biol Sci; 2019 Sep 15; 15(8):1696-1711. PubMed ID: 31360112
    [Abstract] [Full Text] [Related]

  • 40. Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling.
    Wu X, Tang W, Marquez RT, Li K, Highfill CA, He F, Lian J, Lin J, Fuchs JR, Ji M, Li L, Xu L.
    Oncotarget; 2016 Mar 08; 7(10):11708-23. PubMed ID: 26887043
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.